1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NKTR CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA KIAA1468 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA STMN1 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA RFX7 CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA FGF9 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA CTC-398G3.6 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA AC090094.1 CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA ZNF195 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA IDH2 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA PXN CTRPv2 pan-cancer AAC -0.17 4e-06
Download CSV